Here is What Hedge Funds Think About Calithera Biosciences Inc (CALA)

Judging by the fact that Calithera Biosciences Inc (NASDAQ:CALA) has witnessed bearish sentiment from the entirety of the hedge funds we track, it’s safe to say that there were a few hedgies that slashed their entire stakes in the third quarter. Interestingly, Jean-Marie Eveillard’s First Eagle Investment Management dropped the biggest stake of the “upper crust” of funds studied by Insider Monkey, worth close to $0.8 million in stock, and Mark Lampert’s Biotechnology Value Fund / BVF Inc was right behind this move, as the fund said goodbye to about $0.5 million worth of shares.

Let’s also examine hedge fund activity in other stocks similar to Calithera Biosciences Inc (NASDAQ:CALA). We will take a look at Perceptron, Inc. (NASDAQ:PRCP), Innodata Inc (NASDAQ:INOD), InfuSystem Holdings, Inc. (NYSEAMEX:INFU), and Netlist, Inc. (NASDAQ:NLST). This group of stocks’ market values are similar to CALA’s market value.

As you can see these stocks had an average of 4 hedge funds with bullish positions and the average amount invested in these stocks was $9 million. That figure was $12 million in CALA’s case. Perceptron, Inc. (NASDAQ:PRCP) is the most popular stock in this table. On the other hand InfuSystem Holdings, Inc. (NYSEAMEX:INFU) is the least popular one with only 3 bullish hedge fund positions. Compared to these stocks Calithera Biosciences Inc (NASDAQ:CALA) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None